Zhongzhi Pharmaceutical Holdings Limited
3737.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$620.15M
Close$
Share Statistics
| Market cap | $620.15 Million |
|---|---|
| Enterprise Value | $546.22 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.02 |
| Beta | 0.42 |
| Outstanding Shares | 843,744,500 |
Return
| Return on Equity | 3.46% |
|---|---|
| Return on Assets | 2.17% |
| Return on Invested Capital | 2.76% |
Valuation & Multiples
| P/E Ratio | 29.38 |
|---|---|
| PEG | 774.8 |
| Price to Sales | 0.18 |
| Price to Book Ratio | 0.74 |
| Enterprise Value to Revenue | 0.15 |
| Enterprise Value to EBIT | 16.82 |
| Enterprise Value to Net Income | 14 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhongzhi Pharmaceutical Holdings Limited
2,168 employees
CEO: Ying Feng Lai Zhongzhi Pharmaceutical Holdings Limited, an investment holding firm based in the People's Republic of China, focuses on the entire lifecycle of pharmaceutical products, from research and development to manufacturing and distribution. It...